clonidine has been researched along with Brain Vascular Disorders in 21 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
Excerpt | Relevance | Reference |
---|---|---|
"Thirty patients with old post-stroke spastic hemiparesis took part in the investigation." | 1.29 | Mechanisms of tizanidine action on spasticity. ( Georgiev, D; Milanov, I, 1994) |
"On the spastic side a reflex with prolonged latencies and durations, as well as with decreased amplitudes and thresholds of both reflex responses was found." | 1.28 | Flexor reflex for assessment of common interneurone activity in spasticity. ( Milanov, IG, 1992) |
"Treatment with clonidine significantly slowed the rate of recovery (Kruskal-Wallis H = 8." | 1.28 | Clonidine impairs recovery of beam-walking after a sensorimotor cortex lesion in the rat. ( Davis, JN; Goldstein, LB, 1990) |
"It is hypothesized that enlargement of berry aneurysms, the progression of cerebral atherosclerosis, and embolism from carotid lesions might all be decreased by the selection of antihypertensive agents which decrease blood velocity." | 1.26 | Effects of antihypertensive drugs on blood velocity: implications for prevention of cerebral vascular disease. ( Spence, JD, 1977) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (52.38) | 18.7374 |
1990's | 9 (42.86) | 18.2507 |
2000's | 1 (4.76) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, Y | 1 |
Yamada, S | 1 |
Ishima, T | 1 |
Hayashi, M | 1 |
Tomita, T | 1 |
Hayashi, E | 1 |
Ram, CV | 2 |
Eninia, GI | 1 |
Smeltere, ES | 1 |
Godlevska, MA | 1 |
Uzulinia, IP | 1 |
Zamotaev, IP | 1 |
Abramova, VG | 1 |
Stankovskaia, IM | 1 |
Sattar, MA | 1 |
Johns, EJ | 1 |
Prattichizzo, FA | 1 |
Galetta, F | 1 |
Bonechi, I | 1 |
Giusti, C | 1 |
Milanov, I | 1 |
Georgiev, D | 1 |
Goldberg-Stern, H | 1 |
Atlas, D | 1 |
Schwartz, L | 1 |
Achiron, A | 1 |
Ziv, I | 1 |
Djaldetti, R | 1 |
Zoldan, Y | 1 |
Melamed, E | 1 |
Lockette, W | 1 |
Kirkland, K | 1 |
Farrow, S | 1 |
Medvedev, OS | 2 |
Kunduzova, OR | 2 |
Murashev, AN | 2 |
Medvedeva, NA | 2 |
Spence, JD | 1 |
Zweifler, AJ | 1 |
Esler, M | 1 |
Milanov, IG | 1 |
Goldstein, LB | 1 |
Davis, JN | 1 |
Medici, M | 1 |
Pebet, M | 1 |
Ciblis, D | 1 |
Meese, RB | 1 |
Regli, F | 1 |
Bauer, GE | 2 |
Raftos, J | 1 |
Lewis, RG | 1 |
Stokes, GS | 1 |
Mitchell, AS | 1 |
Young, AA | 1 |
Maclachlan, I | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Phase I-II Clinical Trial to Determine the Safety of Clonidine in Infants With Hypoxic Ischemic Encephalopathy During Therapeutic Hypothermia[NCT01862250] | Phase 1/Phase 2 | 13 participants (Actual) | Interventional | 2013-10-03 | Completed | ||
Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment: Double Blinded Comparison Between Botulinum Toxin and Baclofen.[NCT02462317] | Phase 4 | 184 participants (Actual) | Interventional | 2015-04-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Intravenous morphine (mg/kg) was given. The standard dose is 0.05 mg/kg per dose (NCT01862250)
Timeframe: Up to 2 days
Intervention | mg/kg (Median) |
---|---|
Clonidine Infants With HIE | 0.02 |
Babies were assessed after administration of clonidine for the presence or absence of shivering. (NCT01862250)
Timeframe: 48hrs
Intervention | Participants (Count of Participants) |
---|---|
Clonidine Infants With HIE | 0 |
"Trough clonidine blood levels were measured after 4-7 doses of clonidine were given intravenously with a dosing interval of every 8 hrs. Mean and standard deviation (SD) of the number of doses given prior to levels being drawn was 5.3 (mean) and 0.37 (SD).~Time after last dose before measurement was 9hrs (mean) and 2.7hrs (SD)." (NCT01862250)
Timeframe: 3 days
Intervention | ng/ml (Median) |
---|---|
Clonidine Infants With HIE | 0.6 |
Following 2 hours of therapeutic hypothermia, the temperature of the thermo-blanket is adjusted up half degree per hour allowing passive rewarming until 36.5 degrees is reached (NCT01862250)
Timeframe: Beginning at 72 hours up to 12 hours
Intervention | Hours (Median) |
---|---|
Clonidine Infants With HIE | 8.7 |
2 reviews available for clonidine and Brain Vascular Disorders
Article | Year |
---|---|
Hypertensive crisis.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Dia | 1984 |
Hypertensive cardiovascular emergencies.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Dia | 1985 |
2 trials available for clonidine and Brain Vascular Disorders
Article | Year |
---|---|
A double-blind, long-term study of tizanidine ('Sirdalud') in spasticity due to cerebrovascular lesions.
Topics: Adult; Aged; Baclofen; Cerebrovascular Disorders; Clinical Trials as Topic; Clonidine; Double-Blind | 1989 |
[Treatment of vascular headaches].
Topics: Adrenergic beta-Antagonists; Carbamazepine; Cerebrovascular Disorders; Clonidine; Ergotamine; Female | 1973 |
17 other studies available for clonidine and Brain Vascular Disorders
Article | Year |
---|---|
Clonidine preconditioning decreases infarct size and improves neurological outcome from transient forebrain ischemia in the rat.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agon | 2004 |
Reduced alpha 2-adrenoceptor binding in lower brainstem of stroke-prone spontaneously hypertensive rats.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Brain Stem; Cerebrovascular Disorders; Clonidine | 1984 |
[Characteristics of the action of gemiton, adelfan and dopegit on cerebral circulation in arterial hypertension].
Topics: Aged; Antihypertensive Agents; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disea | 1984 |
[Withdrawal syndrome in the treatment of arterial hypertension with clofelin].
Topics: Adult; Aged; Cerebrovascular Disorders; Clonidine; Humans; Hypertension; Male; Middle Aged; Substanc | 1983 |
Evidence for an alpha 1-adrenoceptor subtype mediating adrenergic vasoconstriction in Wistar normotensive and stroke-prone spontaneously hypertensive rat kidney.
Topics: Adrenergic alpha-Antagonists; Amlodipine; Animals; Cerebrovascular Disorders; Clonidine; Dose-Respon | 1994 |
[Therapy of arterial hypertension associated with acute stroke. Current trends and problems].
Topics: Acute Disease; Aged; Antihypertensive Agents; Blood Pressure Monitors; Cerebral Hemorrhage; Cerebrov | 1994 |
Mechanisms of tizanidine action on spasticity.
Topics: Adult; Aged; Cerebrovascular Disorders; Clonidine; Electromyography; Female; H-Reflex; Hemiplegia; H | 1994 |
Detection and measurement of an endogenous clonidine-displacing substance in human cerebrospinal fluid.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Binding, Competitive; Cerebrospinal Fluid Proteins; Cere | 1993 |
Alpha 2-adrenergic agonists increase cellular lactate efflux.
Topics: Adrenergic alpha-Agonists; Animals; Body Temperature Regulation; Cells, Cultured; Cerebrovascular Di | 1996 |
Chronopharmacological dependence of antihypertensive effects of the imidazoline-like drugs in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Circadian Rhythm; Cloni | 1998 |
Influence of sinoaortic barodenervation on the hypotensive effects of imidazoline-like drugs in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cerebrovascular Disorders; Circadian Rhythm; Cloni | 1999 |
Effects of antihypertensive drugs on blood velocity: implications for prevention of cerebral vascular disease.
Topics: Animals; Antihypertensive Agents; Blood Circulation; Blood Flow Velocity; Cerebrovascular Disorders; | 1977 |
Factors influencing the choice of antihypertensive agents.
Topics: Age Factors; Aldosterone; Cerebrovascular Disorders; Clonidine; Depression; Diabetes Complications; | 1976 |
Flexor reflex for assessment of common interneurone activity in spasticity.
Topics: Adult; Aged; Anti-Anxiety Agents; Baclofen; Benzodiazepines; Benzodiazepinones; Cerebrovascular Diso | 1992 |
Clonidine impairs recovery of beam-walking after a sensorimotor cortex lesion in the rat.
Topics: Animals; Brain Injuries; Cerebral Cortex; Cerebrovascular Disorders; Clonidine; Disease Models, Anim | 1990 |
Treatment of hypertension in the elderly.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Cerebrovascular Disorders; Clonidine; Di | 1974 |
Clonidine in the treatment of severe hypertension.
Topics: Adult; Anesthesia, General; Cerebrovascular Disorders; Clonidine; Coronary Disease; Depression; Huma | 1973 |